ଫୁସଫୁସ କ୍ୟାନ୍ସର (ନନ୍-ସ୍ମଲ୍ ସେଲ୍)
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
କିଏ ଯୋଗ ଦେଇପାରିବେ ବୟସ୍କମାନେ
ବୟସ 18+ ବର୍ଷ
ଅଧ୍ୟୟନର ପ୍ରକାରଫେଜ୍ 3: ସାଧାରଣ ଚିକିତ୍ସା ସହିତ ତୁଳନା
What it testsଗୋଟେ medicine
କିଏ ଯୋଗ ଦେଇପାରିବେ ଆଉ କିଏ ପାରିବେ ନାହିଁ, ତାହାର ପୂରା ତାଲିକା ରେଜିଷ୍ଟ୍ରିରେ ଅଛି। ଟ୍ରାଏଲ୍ ଟିମ୍କୁ ପଚାରନ୍ତୁ, କିମ୍ବା ଆମକୁ ଲେଖନ୍ତୁ ଆଉ ଆମେ ଏହାକୁ ସହଜ ଭାଷାରେ ବୁଝେଇଦେବୁ।
କେଉଁଠିକୁ ଯିବେ
ଏହି ଟ୍ରାଏଲ୍ ପାଇଁ ଭାରତରେ 18 ଟି ହସ୍ପିଟାଲ୍ ରୋଗୀ ନେଉଛନ୍ତି।
Hemato Oncology Clinicଅହମ୍ମଦାବାଦDirections ↗
KLES Dr. Prabhakar Kore Hospital & M.R.CବେଲାଗାଭିDirections ↗
SRV Hospitalsବେଙ୍ଗାଲୁରୁDirections ↗
All India Institute of Medical Sciencesଭୁବନେଶ୍ୱରଦିଗ ↗
Ashwin Hospitalକୋଏମ୍ବାଟୁରDirections ↗
Nizam's Institute of Medical Sciencesହାଇଦ୍ରାବାଦDirections ↗
Krishna Institute of Medical Sciences - KaradକରଡDirections ↗
Kolhapur Cancer Centre Private LimitedକୋଲାପୁରDirections ↗
HCG Manavata Cancer Centreନାସିକଡିରେକ୍ସନ୍ସ ↗
Advanced Centre for Treatment Research and Education in Cancerନଭି ମୁମ୍ବାଇDirections ↗
Jawaharlal Institute Of Postgraduate Medical Education And Researchପୁଡୁଚେରୀଦିଗ ↗
Grant Medical Foundation - Ruby Hall ClinicପୁଣେDirections ↗
Sahyadri Super Speciality HospitalପୁଣେDirections ↗
Lifepoint Multispeciality HospitalପୁଣେDirections ↗
Regional Cancer Centre - ThiruvananthapuramଥiruvananthapuramDirections ↗
Pacific Medical College & HospitalଉଦୟପୁରDirections ↗
Tata Memorial Centre - Homi Bhabha Cancer HospitalବାରଣାସୀDirections ↗
Mahatma Gandhi Cancer Hospital and Research InstituteବିଶାଖାପାଟଣାDirections ↗
ରେଜିଷ୍ଟ୍ରି ସାରାଂଶ (ଟେକ୍ନିକାଲ୍)
The purpose of this study is to assess if adding LY3537982 (olomorasib) in combination with standard of care anti-cancer drugs is more effective than standard of care in participants with untreated advanced NSCLC. NSCLC must have a change in a gene called KRAS G12C. Study participation, including follow-up, could last up to 3 years, depending on how you and your lung cancer are doing.
ପ୍ରାୟୋଜକ: Eli Lilly and Company
ClinicalTrials.gov ରେ NCT06119581
ରେଜିଷ୍ଟ୍ରିରେ ଶେଷ ଅପଡେଟ୍ 7 Oct 2026 · ଆମ ଦ୍ୱାରା 20 Oct 2026 ରେ ପଢ଼ାଯାଇଛି